期刊文献+

多药耐药相关蛋白在非小细胞肺癌中的表达和预后 被引量:1

The Study on Expression of Multidrug Resistance-Associated Protein and Its Relation With Prognosis in Non-Small Cell Lung Cancer
下载PDF
导出
摘要 目的 :研究非小细胞肺癌中多药耐药相关蛋白 (MRP)的表达同临床病理特征和病人预后生存期的关系。方法 :采用免疫组织化学S P法检测 6 2例非小细胞肺癌中MRP的表达。结果 :6 2例非小细胞肺癌中MRP总阳性率为 83.88% (5 2 / 6 2 ) ,强阳性率为 4 6 .77% (2 9/ 6 2 ) ,其中鳞癌的阳性率为 87.5 0 % (35 / 4 0 ) ,腺癌为 77.2 7%(17/ 2 2 )。MRP表达与患者性别、组织分化程度、淋巴结转移均无关。MRP表达阴性者术后平均生存期为 (6 9.81± 17.4 1)月 ,表达阳性者为 (2 5 .38± 4 .4 6 )月 ,二者差异具有显著性 (P =0 .0 15 6 )。鳞癌中MRP阴性和阳性者术后生存期存在显著差异 (P =0 .0 15 3)。结论 :非小细胞肺癌中 ,尤其是鳞状细胞癌MRP的表达与术后生存期呈负相关 ,是影响病人预后的因素。MRP阴性表达者术后生存期相对较长。 Objective: This paper was to explore the relationships between expression of multidrug resistance associated protein (MRP) and clinicopathological parameters and prognosis. Methods: We detected the expression of MRP by using method of immunohistochemistry in 62 patients with non small cell lung cancer (NSCLC). Results: Our study of tumor tissue confirmed the plasma membrane or cytoplasm locations of the MRP. We found that the majority (83.88%) patients with NSCLC had detectable levels of MRP, and strong MRP expression was detected in 46.77% patients. But no potentially confounding correlation was observed between MRP expression and any clinicopathological parameters examined, including sex, histological type, tumor cell differentiation, lymphatic metastasis (P>0.05). The mean survival period of the patients with MRP negative expression was (69.81±17.41) months, and that of the patients with MRP positive expression was (25.38±4.46) months. Log rank test suggested that the difference between them was significant (P=0.0156). Furthermore, in squamous cell cancer we also found the statistically significant difference between the mean survival period of patients with MRP positive expression and those of patients with MRP negative expression (P=0.0153). Conclusion: High expression of MRP was predictive for worse survival, and it was a independent factor that affected prognosis. The mean survival period of patients with MRP negative expression was relative long.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2002年第5期337-340,共4页 Journal of China Medical University
基金 教育部留学回国人员科研启动基金资助项目(2 0 0 2 2 47)
关键词 多药耐药相关蛋白 非小细胞肺癌 免疫组织化学 预后 multidrug resistance associated protein non small cell lung cancer immunohistochemistry prognosis
  • 相关文献

参考文献11

  • 1[1]Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line[J]. Science, 1992, 258(5088): 1650-1654.
  • 2[2]Brock I, Hipfner DR, Nielsen BS, et al. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells[J]. Cancer Res, 1995, 55(3): 459-62.
  • 3[3]Krishnamachary N, Center MS. The MRP gene associated with a non-p-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein[J]. Cancer Res, 1993, 53(16): 3658-3661.
  • 4[4]Rappa G, Finch RA, Sartorelli AC, et al. New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models[J]. Biochem pharmacol, 1999, 58(4): 557-562.
  • 5[5]Hipfner DR, Deeley RG, Cole SP. Structural, mechanistic and clinical aspects of MRP1[J]. Biochem Biophys Acta, 1999, 1461(2): 359-376.
  • 6[6]Konig J, Nies AT, Cui Y, et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance[J]. Biochem Biophys Acta, 1999, 1461(2): 377-394.
  • 7[7]Wright SR, Boag AA, Valdimarsson G, et al. Immunohistochemical detection of multidrug resistance protein in human drug cancer and normal lung[J]. Clin Cancer Res, 1998, 4(9): 2279-2289.
  • 8[8]Almquist KC, Loe DW, Hipfner DR, et al. Characterization of the Mr 190 000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells[J]. Cancer Res, 1995, 55(1): 102-110.
  • 9[9]Young LC, Campling BG, Voskoglou-Nomikos T, et al. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response[J]. Clin Cancer Res, 1999, 5(3): 673-680.
  • 10[10]Nooter K, Bosman FT, Burger H, et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer[J]. Ann Oncol, 1996, 7(1): 75-81.

同被引文献3

  • 1Wartenberg M,Ling FC,Muschen M,et al.Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species.FASEB J,2003,17:503-505.
  • 2Katrina MC,Tiomthy JW,Nancy AL,et al.Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance(MDR1)gene.Cancer Res,2002,62:3387-3394.
  • 3樊利芳,刁路明,陈德基,刘铭球,朱丽琴,李红钢,唐志佼,夏东,刘绚,陈洪雷.肺癌组织中缺氧诱导因子-1α的表达及其与凋亡和增殖的关系[J].癌症,2002,21(3):254-258. 被引量:72

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部